Falsified Medical Products in Francophone Sub-S...

By HEOR Staff Writer

October 9, 2023

The Challenges of Substandard Medical Products Substandard and falsified (SF) medical products pose a significant thr...
AI and Value-Based Care: Machine Learning’s Potential in Reducing Healt...
Abu Dhabi Global Healthcare Week Partners with Digital Health New York to Boo...
Direct-Acting Oral Anticoagulants: A Comparative Study on Value and Pricing
Inflation Reduction Act: A Game Changer for Cardiovascular Therapies Access
Oracle’s Major Moves in the Healthcare Industry
The Global Impact of NICE Decision Outcomes in Health Technology Assessment
Patent Exclusivities and High Costs: The Challenge of Generic Competition for...
NICE Guidelines Set to Reduce Unnecessary Colonoscopies
Transforming Medical Technology: The Launch of the Innovative Devices Access ...
WHO Launches Groundbreaking Online Repository for Evidence-Informed Decision-...
Technologies Reshaping Biotherapeutics Manufacturing: An EU Perspective
USP and SAHPRA: A Partnership for Health Regulatory Excellence